Critical window hypothesis of hormone therapy and cognition
- 1 June 2013
- journal article
- review article
- Published by Wolters Kluwer Health in Menopause
- Vol. 20 (6) , 695-709
Abstract
Objective The critical window hypothesis of hormone therapy (HT) and cognitive function states that the effects of HT depend on timing of initiation with respect to age, the menopausal transition, or both, and that optimal effects are evident with early initiation. This article reviews clinical studies that bear on this hypothesis. Methods Recognizing that the typical pattern of HT use is early HT initiation, this review describes findings from observational studies of ever use of HT and observational studies that looked specifically at the timing of HT on Alzheimer’s disease (AD) and cognitive test performance. Randomized trials of HT and verbal memory are discussed, and neuroimaging studies bearing on the hypothesis are reviewed. Results Observational data suggest that HT generally reduces the risk of AD. Three of three observational studies that specifically examined the timing of initiation in relation to AD risk each provide support for the window, whereas three of five observational studies of HT timing and cognitive test performance do. Randomized clinical trials of estrogen therapy in younger women find support for the hypothesis. Conjugated equine estrogens/medroxyprogesterone acetate increases risks regardless of timing. Little is known about the cognitive effects of other combination HT formulations. Conclusions A definitive trial to test the critical window hypothesis is not feasible. Evidence drawn from other sources provides initial support for the hypothesis. Although these findings are relevant to women who use HT to treat vasomotor symptoms, HT is currently not indicated for the treatment of cognitive complaints or for dementia prevention.Keywords
This publication has 106 references indexed in Scilit:
- Postmenopausal hormone therapy, timing of initiation, APOE and cognitive declineNeurobiology of Aging, 2012
- Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior HysterectomyJAMA, 2011
- Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in lifeBrain Research, 2011
- Timing of hormone therapy and dementia: The critical window theory revisitedAnnals of Neurology, 2010
- Early menopausal hormone use influences brain regions used for visual working memoryMenopause, 2010
- A cross-sectional study of hormone treatment and hippocampal volume in postmenopausal women: Evidence for a limited window of opportunity.Neuropsychology, 2010
- Effects of botanicals and combined hormone therapy on cognition in postmenopausal womenMenopause, 2009
- Brain Volumes, Cognitive Impairment, and Conjugated Equine EstrogensThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2009
- Midlife Serum Cholesterol and Increased Risk of Alzheimer’s and Vascular Dementia Three Decades LaterDementia and Geriatric Cognitive Disorders, 2009
- Brief report: Coronary heart disease events associated with hormone therapy in younger and older womenJournal of General Internal Medicine, 2006